Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

INCB3344

INCB3344 is a potent, selective and orally bioavailable CCR2 antagonist with IC50 values of 5.1 nM (hCCR2) and 9.5 nM (mCCR2) in binding antagonism and 3.8 nM (hCCR2) and 7.8 nM (mCCR2) in antagonism of chemotaxis activity.

Product Specifications

CAS Number

[1262238-11-8]

UNSPSC

12352005

Target

CCR

Type

Reference compound

Related Pathways

GPCR/G Protein; Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Endocrinology

Assay Protocol

https://www.medchemexpress.com/INCB3344.html

Purity

99.08

Solubility

DMSO : 200 mg/mL (ultrasonic)

Smiles

CCO[C@H]1CN([C@]2([H])CC[C@@](CC2)(C3=CC4=C(OCO4)C=C3)O)C[C@@H]1NC(CNC(C5=CC(C(F)(F)F)=CC=C5)=O)=O

Molecular Formula

C29H34F3N3O6

Molecular Weight

577.59

References & Citations

[1]Xue CB, et al. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2. Bioorg Med Chem Lett. 2010 Dec 15;20 (24) :7473-8|[2]Brodmerkel CM, et al. Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. J Immunol. 2005 Oct 15;175 (8) :5370-8.|[3]Chan CT, et al. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice. Hypertension. 2012 Nov;60 (5) :1207-12.|[4]Dansereau MA, et al. Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem. 2008 Jul;106 (2) :757-69.|[5]Zhao W, et al. Enrichment of Ly6Chi monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model. Hum Vaccin Immunother. 2017 Dec 2;13 (12) :2872-2882.|[6]Aye-Mon A, et al. CCR2 upregulation in DRG neurons plays a crucial role in gastric hyperalgesia associated with diabetic gastropathy. Mol Pain. 2018 Jan-Dec;14:1744806917751322.|[7]Cassini MF, et al. Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2018 Oct;29 (10) :2471-2481.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

CCR2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mouse Monoclonal CD20 Antibody (rIGEL/773) [Alexa Fluor 488]
NBP2-54591AF488 100 µL

Mouse Monoclonal CD20 Antibody (rIGEL/773) [Alexa Fluor 488]

Ask
View Details
VASH2 ORF Vector (Human) (pORF)
49429012 1.0 µg DNA

VASH2 ORF Vector (Human) (pORF)

Ask
View Details
Tissue Factor (F3) Human shRNA Lentiviral Particle (Locus ID 2152)
TL313116V 500 µL Each

Tissue Factor (F3) Human shRNA Lentiviral Particle (Locus ID 2152)

Ask
View Details
CRHR1 Antibody
A18011-100UG 100 µg

CRHR1 Antibody

Ask
View Details